Paclitaxel protein-bound Intravenous and Hepatic dysfunction
Result of checking the interaction of drug Paclitaxel protein-bound Intravenous and disease Hepatic dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Paclitaxel is extensively metabolized by the liver. Patients with moderate to severe hepatic impairment may be at increased risk for hepatotoxicity. Additionally, myelotoxicity of paclitaxel may be exacerbated in patients with serum total bilirubin >2 times ULN. Therapy with paclitaxel should be administered cautiously and at a reduced dosage in patients with compromised hepatic function.
- "Product Information. Taxol (paclitaxel)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: paclitaxel protein-bound
Brand Name: Abraxane
Synonyms: Paclitaxel protein-bound, PACLitaxel (Protein Bound)
Paclitaxel protein-bound Intravenous - zaburzenia czynności wątroby 
Paclitaxel protein-bound Intravenous - disfunção hepática 
Paclitaxel protein-bound Intravenous - disfungsi hepatik 
Paclitaxel protein-bound Intravenous - disfungsi hati 
Paclitaxel protein-bound Intravenous - disfunzione epatica 
Paclitaxel protein-bound Intravenous - dysfonctionnement hépatique 
Paclitaxel protein-bound Intravenous - Leberfunktionsstörung 
Paclitaxel protein-bound Intravenous - disfunción hepática 
Paclitaxel protein-bound Intravenous - печеночная дисфункция 
Paclitaxel protein-bound Intravenous - hepatik disfonksiyon 
Paclitaxel protein-bound Intravenous - ضعف الكبد 
Paclitaxel protein-bound Intravenous - 肝功能障碍